@article{ref1,
title="Adoption, penetration, and effectiveness of a secondary risk screener for intimate partner violence: evidence to inform screening practices in integrated care settings",
journal="General hospital psychiatry",
year="2018",
author="Iverson, Katherine M. and Sorrentino, Anneliese E. and Bellamy, Scarlett L. and Grillo, Alessandra R. and Haywood, Terri N. and Medvedeva, Elina and Roberts, Christopher B. and Dichter, Melissa E.",
volume="51",
number="",
pages="79-84",
abstract="OBJECTIVE: Veterans Health Administration (VHA) has implemented screening for past-year intimate partner violence (IPV) in some healthcare facilities along with secondary screening of risk for severe violence among those screening positive in order to facilitate follow-up care for high-risk patients. We evaluated the adoption, penetration, and effectiveness of secondary screening as a tool to facilitate timely follow-up services. <br><br>METHODS: Retrospective review of medical records (screening and healthcare use) of 774 women screening positive for past-year IPV (IPV+) at 11 facilities nationwide from April 2014-April 2016. Chi-square and t-tests examined factors related to secondary screening. <br><br>RESULTS: Three of eleven (27.3%) facilities that implemented primary IPV screening adopted secondary screening. At adopting sites, 56.4% eligible (i.e., IPV+) women received secondary screening. Among 185 IPV+ women who completed secondary screening, 33.0% screened positive for severe IPV. Screening positive during secondary screening was associated with higher rate of psychosocial care within 60 days (73.8% vs. 54.0% of IPV+ patients screening negative; p < .05), posttraumatic stress disorder diagnosis (31.1% vs. 15.3%; p < .05), and being physically threatened or harmed (>50% vs. <15%; p < .001). <br><br>CONCLUSIONS: Secondary risk assessment following IPV screening may expedite access to psychosocial follow-up care in integrated healthcare settings. However, program uptake needs to be enhanced.<br><br>Published by Elsevier Inc.<p /> <p>Language: en</p>",
language="en",
issn="0163-8343",
doi="10.1016/j.genhosppsych.2018.01.002",
url="http://dx.doi.org/10.1016/j.genhosppsych.2018.01.002"
}